A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke "DECIDE"
Recruiting
Phase N/A Results N/ASummary of Purpose
The purpose of the protocol is to evaluate injection intervals and treatment modalities up to 3 years follow-up of botulinum toxin A (BoNT-A) in adult patients suffering from upper limb spasticity after stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 30 April 2012.
| 1 Dec 2010 | 10 Nov 2010 | 1 Oct 2014 | 1 Dec 2014 | 1 Apr 2012 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample
Contacts
- Ipsen Central Contact
View Trial Locations
Recruitment
- Enrollment: 200
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 24 locations, 1 country
Principal Investigator
- Patrick Cabri, MD
Ipsen
